معرفی
Professor David Gillatt is a leading urological oncologist and robotic surgeon at Macquarie University, specializing in prostate and bladder cancer treatments. He holds roles as Director of Medical and Surgical Services at MQ Health, Head of Urology Clinical Discipline, and Professor of Urological Oncology and Robotics. With over 25 years of experience, he has performed over 2,000 major resections and pioneered the Enhance Recovery program for cystectomy, a globally recognized innovation. His clinical expertise includes robotic surgery training programs and advanced pelvic cancer surgery.
Education and Qualifications: Gillatt holds a Bachelor of Surgery and Medicine from the University of Manchester (1980), Fellowships from the Royal College of Surgeons of England (1993), Edinburgh (1984), and the Royal Australasian College of Surgeons (2015).
Research Focus: His work spans clinical trials and basic science, including biomarker discovery for prostate cancer (e.g., IGFs and volatile diagnostics) and the impact of ketamine abuse on bladder function. He led the Bristol Chief Investigator role for the national PROTECT study and established the Prostate Cancer Care and Research Centre in the UK.
Projects and Collaborations: Key projects include robotic surgery training methodologies, high-dose vitamin D trials for prostate cancer (Pros-D), and molecular imaging advancements for bladder cancer using upconversion nanoparticles.
Awards and Recognition: His fellowships (FRCS, FRACS) and contributions to global urological advancements highlight his expertise. He is recognized for strengthening Macquarie’s multidisciplinary prostate cancer care model.
Labs and Teams: He leads surgical and research teams at Macquarie University Hospital, collaborating on bioreactor technologies and cancer radioimmunotherapy initiatives.
